Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valeo Pharma Inc VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


GREY:VPHIF - Post by User

Comment by kooter33on Jun 07, 2021 4:28pm
173 Views
Post# 33342283

RE:1.20

RE:1.20
JACKTHEBEAR2 wrote: When we crack 1.20 things should work towards 1.40 and a new range without news will take place. Bottom line this is worth alot more then current levels.The science will bare fruit soon.

Valeo needs institutional support, they have 2 analysts reports which show that the next 12 months VPH should be at $3.30 to $3.50.  Right now all we are seeing is a "rinse and repeat" accumulation 1.10 to 1.15 again and again.  This company is in a near term explosive growth phase and it will be demonstrated upon the release of Q2 and Q3 reports.  Multiple quarters coming of increased revenues and profitable next year.
I am willing to wait and accumulate the rinse and repeat procedure until it shows signs of breaking out and then I will stop accumulating and watch the ascension to the analysts targets within the next 12 months or sooner. JMHO.
<< Previous
Bullboard Posts
Next >>